Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo Controlled, Multicenter, Randomized Double Blind Trial to Evaluate the Safety and Effectiveness of IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction

NCT01226563 is registered in ClinicalTrials.gov with Bellerophon BCM LLC as lead sponsor.

NCT NCT01226563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01226563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo Controlled, Multicenter, Randomized Double Blind Trial to Evaluate the Safety and Effectiveness of IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction
Lead sponsor
Bellerophon BCM LLC
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2012
Completion date
December 31, 2015
Enrollment
303 (actual)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, congestive heart failure, st-elevation myocardial infarction